Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 2001 Mar;35(2):145–154. doi: 10.1023/A:1017921702775

CB.Hep-1 hybridoma growth and antibody production using protein-free medium in a hollow fiber bioreactor

R Valdés 1,✉, N Ibarra 2, M González 2, T Alvarez 2, J García 2, R Llambias 3, C A Pérez 4, O Quintero 5, R Fischer 6
PMCID: PMC3449458  PMID: 19003291

Abstract

The protein-free medium TurboDoma HP.1 (THP.1) was used to produce the CB.Hep-1 monoclonal antibody (mAb) in a CP-1000 hollow fiber bioreactor (HFB). This mAb is used for the immunopurification of recombinant hepatitis B surface antigen (rHBsAg), which is included in a vaccine preparation against the Hepatitis B Virus. By using the experimental conditions tested in this work we were able to generate more than 433 mg of IgG in 43 days. The maximum antibody concentration obtained was about 2.4 mg ml-1and the IgG production per day was approximately 11 mg of monoclonal antibody, which constitutes a good concentration value in comparison to the results obtained in ascitic fluid, where concentration for this hybridoma was around 3 mg ml-1. We used different analytical methods to control the quality of mAbs, obtained from the in vitro system. They included affinity constant determination, analysis of N-glycan structures, immunoaffinity chromatography and antigen binding properties. The results obtained suggest that no significant changes occurred in the mean characteristics of the mAb harvested from the bioreactor during the 43 days of cultivation.

Keywords: hollow fiber bioreactor, hybridoma, protein-free medium

Full Text

The Full Text of this article is available as a PDF (249.5 KB).

References

  1. Abel CA, Spiegelberg HL, Grey HM. The carbohydrate content of fragments and polypeptide chains of human gammamyeloma proteins of different heavy chain subclasses. Biochemistry. 1968;7:1271–1275. doi: 10.1021/bi00844a004. [DOI] [PubMed] [Google Scholar]
  2. Beatty JD, Beatty BG, Vlahos WG. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods. 1987;100:173–177. doi: 10.1016/0022-1759(87)90187-6. [DOI] [PubMed] [Google Scholar]
  3. Bertheussen K. Growth of cells in a new defined protein-free medium. Cytotechnology. 1993;11:219–231. doi: 10.1007/BF00749873. [DOI] [PubMed] [Google Scholar]
  4. Brown J. Therapeutic Monoclonal Antibodies: European Regulatory Issues. In: Borrebaeck CA, Larrick J, editors. Therapeutic Monoclonal Antibodies. New York: Stockton Press; 1990. pp. 321–361. [Google Scholar]
  5. Cosme K, Guerra I, Díaz T, Herrera O. Large Scale Monoclonal Antibody production in ascites using BALB/c and BALB/c-Derived cross-bred mice. Biotec Aplic. 1993;10:12–14. [Google Scholar]
  6. Cosme K, Porras T and Guerra I (1999) Producción de ascitis tumoral rica en anticuerpos monoclonales a partir de las líneas de ratones BALB/c e híbridos de primera generación. Rev. Hispanoamericana de la Ciencia del Animal de Laboratorio. Ed. Animales de Experimentación. 5: 1–8.
  7. Danielson A, Ljunglof A, Lindblom H. One step purification of monoclonal antibodies from mouse ascites. J Immunol Methods. 1988;115:79–88. doi: 10.1016/0022-1759(88)90312-2. [DOI] [PubMed] [Google Scholar]
  8. Fernández de Cossío ME, Díaz T, Galván A, Valdés R, Gonzalez E, Ayala M, Díaz J, Bestagno M, Burrone O, Gavilondo J. Antigen recognition characteristics and comparative performance in immunoaffinity purification of two monoclonal antibodies specific for the hepatitis B virus surface antigen. J Biotechnol. 1997;56:69–80. doi: 10.1016/S0168-1656(97)00103-X. [DOI] [PubMed] [Google Scholar]
  9. Fontirrochi G, Dueñas M, Fernández de Cossio ME, Fuentes P, Pérez M, Mainet D, Ayala M, Gavilondo JV, Duarte CA. A mouse hybridoma cell line secreting IgG and IgM antibodies with specificity for the hepatitis b surface antigen. Biotec Aplic. 1993;10:24–30. [Google Scholar]
  10. Franek F, Dolnikova J. Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration. Cytotechnology. 1991;7:33–38. doi: 10.1007/BF00135636. [DOI] [PubMed] [Google Scholar]
  11. Glassy MC, Tharakan JP. Serum free media in hybridoma culture and monoclonal antibody production. Biotechnol Bioeng. 1988;32:1015–1028. doi: 10.1002/bit.260320809. [DOI] [PubMed] [Google Scholar]
  12. Hendriksen CF, Leeuw W. Production of Monoclonal antibodies by the ascites method in laboratory animals. Res Immunol. 1998;6:529–560. [PubMed] [Google Scholar]
  13. Knazek RA, Gullino PM, Kohler PO, Dedrick RL. Cell culture on artificial capillaries: an approach to tissue growth. Science. 1972;178:65–67. doi: 10.1126/science.178.4056.65. [DOI] [PubMed] [Google Scholar]
  14. Kohn J, Wilchek M. The use of cyanogen bromide and other novel cyanylating agents for the activation of polysaccharide resins. Appl Biotechnol. 1984;9:285–304. [Google Scholar]
  15. Kunkel JP, Jan DCH, Jamieson JC, Butler M. Dissolved oxygen concentration in serum-free continuous culture affects Nlinked glycosylation of monoclonal antibody. J Biotechnol. 1998;62:55–71. doi: 10.1016/S0168-1656(98)00044-3. [DOI] [PubMed] [Google Scholar]
  16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Lowry DH, Rosembrough NJ, Farr AL, Randal RJ. Protein measurements with the folinphenol reagent. J Biol Chem. 1951;193:265–269. [PubMed] [Google Scholar]
  18. Mariorella BL, Winkelhake J, Young J, Moyer B, Bauer R, Hora M, Andya J, Thomson J, Patel T, Parekh R. Effect of culture conditions on IgM antibody structure, pharmacokinetics and activity. Bio/Technology. 1993;11:387–392. doi: 10.1038/nbt0393-387. [DOI] [PubMed] [Google Scholar]
  19. Merten O-W, Keller H, Cabanié L. Development of a protein-free medium for bioreactor cultures of hybridoma cell lines. In: Spier RE, Griffiths JB, Meignier B, editors. Production of Biologicals from Animal Cells in Culture. Oxford, U.K.: Butterworth-Heinemans; 1991. pp. 170–179. [Google Scholar]
  20. Merten O-W, Keller H, Cabanie L, Litwin J, Flamand B. Development of a serum-free medium for hybridoma fermentor cultures. In: Spier RE, Griffiths JB, Stephene J, Crooy PJ, editors. Advances in Animal Cell Biology and Technology for Bioprocesses. Sevenoaks, U.K.: Butterworth; 1989. pp. 263–269. [Google Scholar]
  21. Painter RH, Freedman MH. Isolation and characterization of electrophoretically homogeneous rabbit anti-hapten antibody populations. II A survey of the isoelectric properties of anti-hapten antibodies directed against charged and uncharged haptens. J Biol Chem. 1971;246:66–92. [PubMed] [Google Scholar]
  22. Pentón E, Herrera L, Muzio V, Ramírez V, García A, Duarte C, Ruiz C, Izquierdo M, Pérez L, Fontirrochi G, González M, Nazabal M, Beldarraín A, Padrón G, García J, De la Riva G, Santiago A, Ayan F, Páez R, Agraz A, Díaz R, Quiñones Y. Eur Pat Apl. 1992;480:525. [Google Scholar]
  23. Pentón E, Muzio V, González M. The hepatitis B virus (HBV) infection and its prevention by a recombinant DNA viral surface (rHBsAg) antigen vaccines. Biotec Aplic. 1994;11:1–11. [Google Scholar]
  24. Quintero O, Montesino R, Cremata JA. Two-dimensional mapping of 8-amine-1,3,6-Naphthalene trisulfonic acid derivates of N-linked neutral and sialyloligosaccharides. Anal Bioch. 1998;256:23–32. doi: 10.1006/abio.1997.2420. [DOI] [PubMed] [Google Scholar]
  25. Reisfeld RA. Heterogeneity of rabbit light polypeptide chains. Cold Spring Harbor Symp Quant Biol. 1967;32:291–298. [Google Scholar]
  26. Rothman RJ, Warren L, Vliegenthart JFG, Hard KJ. Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. Biochemistry. 1989;28:1377–1384. doi: 10.1021/bi00429a065. [DOI] [PubMed] [Google Scholar]
  27. Sugasawara RJ, Cahoon BE, Karu E. The influence of murine macrophage-conditioned medium on cloning efficiency, antibody synthesis and growth rate of hybridomas. J Immunol Methods. 1985;79:263–268. doi: 10.1016/0022-1759(85)90106-1. [DOI] [PubMed] [Google Scholar]
  28. Valdés R, Leyva JL, González E, Mainet D, Costa L. Caracterización de anticuerpos monoclonales contra el antígeno de superficie del virus de la hepatitis B. Biotec Aplic. 1994;11:219–224. [Google Scholar]
  29. WHO (1992) Expert Committee on Biological Standardization Forty-second Report. Geneva, CH.

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES